Browse by Medical Category
Accepting New Patients
Go To Programs
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
The bionic pancreas system developed by Boston University investigators proved better than either conventional or sensor-augmented insulin pump therapy at managing blood sugar levels in patients with type 1 diabetes living at home, with no restrictions, in a clinical trial led by a Massachusetts General Hospital physician.
Her Highness Sheikha Moza Bint Nasser of Qatar visited the MGH May 19 for a special presentation about type 1 diabetes treatment and research, islet and whole organ transplantation and the future of a bionic pancreas.
The latest version of a bionic pancreas device has been successfully tested in two five-day clinical trials – one in adults, the other in adolescents – that imposed minimal restrictions on patient activities.
An artificial pancreas system that closely mimics the body's blood sugar control mechanism was able to maintain near-normal glucose levels without causing hypoglycemia in a small group of patients.
Back to Top